Muc1/Cd227 immunohistochemistry in routine practice is a useful biomarker in breast cancers.
Fiche publication
Date publication
janvier 2013
Auteurs
Membres identifiés du Cancéropôle Est :
Dr GARBAR Christian, Pr BENSUSSAN Armand
Tous les auteurs :
Garbar C, Mascaux C, Cure H, Bensussan A
Lien Pubmed
Résumé
Over-expression of MUC1/CD227 is observed in 90% of breast tumors. Classical morphologic description and semi-quantitative digital measurement of MUC1 were performed from immunohistochemical stained slides of 123 routine histological samples. Measures of MUC1 expression showed statistical differences between non tumoral (NT) breast tissue and Ductal Carcinoma In Situ (DCIS) or infiltrating carcinoma (IC), p < 0.0001. Loss of MUC1 was correlated with high Ki67 index (p = 0.001) and loss of hormonal receptors (p = 0.03), whereas no correlations were found with HER2 expression. High-grade DCIS or IC showed increasing loss of apical polarised and cytoplasmic expression of MUC1.
Référence
J Immunoassay Immunochem. 2013;34(3):232-45